AGEN

SEC source: 0000950170-24-046418 · ownership.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2034-02-05

F1 · derivative.exercise_date: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 150,000 Stock Options with an exercise price of $0.63.

SEC source: 0000950170-24-008196 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,211,736

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending January 26, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.66 is the closing price of our Common Stock on January 26, 2024, the payroll date for the pay period ending January 26, 2024.

SEC source: 0000950170-24-004632 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,439,261

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending January 12, 2024. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.64 is the closing price of our Common Stock on January 12, 2024, the payroll date for the pay period ending January 12, 2024.

SEC source: 0000950170-24-001479 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,751.991

Underlying: Common Stock · 25,671.141 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $0.83 per Deferred Stock Unit acquired on January 2, 2024. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000950170-24-001478 · ownership.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,485.882

Underlying: Common Stock · 30,956.376 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $0.83 per Deferred Stock Unit acquired on January 2, 2024. The price of each Deferred Stock Unit acquired on January 2, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000950170-24-001477 · ownership.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,723.314

Underlying: Common Stock · 11,325.503 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $0.83 per Deferred Stock Unit acquired on January 2, 2024. The price of each Deferred Stock Unit acquired on January 2, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000950170-24-000573 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,416,084

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 29, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.83 is the closing price of our Common Stock on December 29, 2023, the payroll date for the pay period ending December 29, 2023.

SEC source: 0000950170-23-070975 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,396,538

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 15, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.69 is the closing price of our Common Stock on December 15, 2023, the payroll date for the pay period ending December 15, 2023.

SEC source: 0000950170-23-067485 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,373,085

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending December 1, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.78 is the closing price of our Common Stock on December 1, 2023, the payroll date for the pay period ending December 1, 2023.

SEC source: 0000950170-23-064994 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,352,358

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 17, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.69 is the closing price of our Common Stock on November 17, 2023, the payroll date for the pay period ending November 17, 2023.

SEC source: 0000950170-23-064833 · ownership.xml · nonDerivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,063

F1 · shares: Represents open market purchase of common stock for cash.

SEC source: 0000950170-24-013560 · ownership.xml · nonDerivative · entry 2

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,725

F1 · shares: Represents open market purchase of common stock for cash.

SEC source: 0000950170-24-013560 · ownership.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,725

F1 · shares: Represents open market purchase of common stock for cash.

SEC source: 0000950170-23-059038 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,328,847

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending November 3, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.84 is the closing price of our Common Stock on November 3, 2023, the payroll date for the pay period ending November 3, 2023.

SEC source: 0000950170-24-013559 · ownership.xml · nonDerivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,391

F1 · shares: Represents open market purchase of common stock for cash.

SEC source: 0000950170-23-054523 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,309,647

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 20, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $0.89 is the closing price of our Common Stock on October 20, 2023, the payroll date for the pay period ending October 20, 2023.

SEC source: 0000899243-23-019942 · doc4.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,291,505

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending October 6, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $1.06 is the closing price of our Common Stock on October 6, 2023, the payroll date for the pay period ending October 6, 2023.

SEC source: 0000950170-23-051971 · ownership.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,397.81

Underlying: Common Stock · 6,585.751 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.42 per Deferred Stock Unit acquired on October 2, 2023. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. This amount also includes a downward adjustment of 27.45 Deferred Stock Units in respect of the grant dated July 3, 2023, as the average closing price used for such calculation incorrectly reflected a stock split and was increased on October 2, 2023 to $1.61 per Deferred Stock Unit.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000950170-23-051969 · ownership.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,080.85

Underlying: Common Stock · 14,927.713 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.42 per Deferred Stock Unit acquired on October 2, 2023. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. This amount also includes a downward adjustment of 62.21 Deferred Stock Units in respect of the grant dated July 3, 2023, as the average closing price used for such calculation incorrectly reflected a stock split and was increased on October 2, 2023 to $1.61 per Deferred Stock Unit.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000950170-23-051963 · ownership.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,529.506

Underlying: Common Stock · 18,001.063 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.42 per Deferred Stock Unit acquired on October 2, 2023. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediatlely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. This amount also includes a downward adjustment of 75.02 Deferred Stock Units in respect of the grant dated July 3, 2023, as the average closing price used for such calculation incorrectly reflected a stock split and was increased on October 2, 2023 to $1.61 per Deferred Stock Unit.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000950170-23-049605 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,276,200

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 22, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $1.18 is the closing price of our Common Stock on September 22, 2023, the payroll date for the pay period ending September 22, 2023.

SEC source: 0000950170-23-047367 · ownership.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,262,312

F1 · security: At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending September 8, 2023. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.

F2 · price: $1.23 is the closing price of our Common Stock on September 8, 2023, the payroll date for the pay period ending September 8, 2023.

SEC source: 0000899243-23-017125 · doc4.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,153.14

Underlying: Common Stock · 13,283.487 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.60 per Deferred Stock Unit acquired on July 3, 2023. The price of each Deferred Stock Unit acquired on July 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-23-017124 · doc4.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,528.442

Underlying: Common Stock · 16,018.322 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.60 per Deferred Stock Unit acquired on July 3, 2023. The price of each Deferred Stock Unit acquired on July 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-23-017126 · doc4.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,812.055

Underlying: Common Stock · 5,860.362 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.60 per Deferred Stock Unit acquired on July 3, 2023. The price of each Deferred Stock Unit acquired on July 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-23-010208 · doc4.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,869.6532

Underlying: Common Stock · 9,869.6532 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.153 per Deferred Stock Unit acquired on April 3, 2023. The price of each Deferred Stock Unit acquired on April 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-23-010207 · doc4.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,510.12

Underlying: Common Stock · 11,901.641 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.153 per Deferred Stock Unit acquired on April 3, 2023. The price of each Deferred Stock Unit acquired on April 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediat1ely preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-23-010206 · doc4.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,951.693

Underlying: Common Stock · 4,354.259 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.153 per Deferred Stock Unit acquired on April 3, 2023. The price of each Deferred Stock Unit acquired on April 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-23-001364 · doc4.xml · derivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024.

SEC source: 0000899243-23-001362 · doc4.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024.

SEC source: 0000899243-23-001360 · doc4.xml · derivative · entry 1

Jeynes-Ellis Allison M · CIK 0001758521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024.

SEC source: 0000899243-23-001356 · doc4.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-01-08

F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024.

SEC source: 0000899243-23-001330 · doc4.xml · derivative · entry 4

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,400,000

Underlying: Common Stock · 2,400,000 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Option was granted on January 5, 2023 and awarded in accordance with the 2019 Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.

SEC source: 0000899243-23-001330 · doc4.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,249,167

F1 · security: Reflects the executive's 2022 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.

F2 · price: $2.45 was the fair market value of Agenus Common Stock on January 5, 2023, the stock issuance date.

SEC source: 0000899243-23-001321 · doc4.xml · derivative · entry 2

KLASKIN CHRISTINE M · CIK 0001288123 · PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,916

Underlying: Common Stock · 162,916 shares

Expires 2033-01-05

F3 · derivative.exercise_date: Option was granted on January 5, 2023 and awarded in accordance with the 2019 Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.

SEC source: 0000899243-23-001321 · doc4.xml · nonDerivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · PFO & PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,937

F1 · security: Reflects the executive's 2022 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.

F2 · price: $2.45 was the fair market value of Agenus Common Stock on January 5, 2023, the stock issuance date.

SEC source: 0000899243-23-001320 · doc4.xml · derivative · entry 2

O'Day Steven J · CIK 0001845281 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-01-05

F3 · derivative.exercise_date: Option was granted on January 5, 2023 and awarded in accordance with the 2019 Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.

SEC source: 0000899243-23-001320 · doc4.xml · nonDerivative · entry 1

O'Day Steven J · CIK 0001845281 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,384

F1 · security: Reflects the executive's 2022 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.

F2 · price: $2.45 was the fair market value of Agenus Common Stock on January 5, 2023, the stock issuance date.

SEC source: 0000899243-23-000503 · doc4.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,608.479

Underlying: Common Stock · 9,893.822 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.590 per Deferred Stock Unit acquired on January 3, 2023. The price of each Deferred Stock Unit acquired on January 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-23-000500 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,725

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $2.590 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

SEC source: 0000899243-23-000498 · doc4.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,597.434

Underlying: Common Stock · 3,619.691 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.590 per Deferred Stock Unit acquired on January 3, 2023. The price of each Deferred Stock Unit acquired on January 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-22-032921 · doc4.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,977.743

Underlying: Common Stock · 3,608.154 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.598 per Deferred Stock Unit acquired on October 3, 2022. The price of each Deferred Stock Unit acquired on October 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-22-032920 · doc4.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,714.657

Underlying: Common Stock · 9,862.289 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.598 per Deferred Stock Unit acquired on October 3, 2022. The price of each Deferred Stock Unit acquired on October 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-22-032917 · doc4.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,944.545

Underlying: Common Stock · 10,102.832 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.598 per Deferred Stock Unit acquired on October 3, 2022. The price of each Deferred Stock Unit acquired on October 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-22-032915 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,486

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $2.598 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

SEC source: 0000899243-22-025326 · doc4.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,369.589

Underlying: Common Stock · 5,068.893 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.85 per Deferred Stock Unit acquired on July 1, 2022. The price of each Deferred Stock Unit acquired prior to July 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-22-025322 · doc4.xml · nonDerivative · entry 1

Hirsch Susan B · CIK 0001827663 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,270

F1 · security: Acquired under the Agenus Inc. Board Compensation Election Policy pursuant to which a director may elect to receive her director fees in shares of Agenus' common stock.

F2 · price: $1.85 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such shares were issued.

F3 · balance_after: The number of shares owned following the reported transaction includes 55,750 shares beneficially owned by the reporting person at the time she was appointed a director, which shares were reported on a Form 3 filed on October 13, 2020. The reporting person has continued to beneficially own such shares since October 13, 2020, but they were inadvertently omitted from Form 4 filings previously filed by the reporting person.

SEC source: 0000899243-22-025325 · doc4.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,841.713

Underlying: Common Stock · 14,192.901 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.85 per Deferred Stock Unit acquired on July 1, 2022. The price of each Deferred Stock Unit acquired prior to July 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-22-025320 · doc4.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,852.368

Underlying: Common Stock · 13,854.975 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $1.850 per Deferred Stock Unit acquired on July 1, 2022. The price of each Deferred Stock Unit acquired prior to July 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

SEC source: 0000899243-22-013874 · doc4.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,300.696

Underlying: Common Stock · 3,405.296 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

F3 · price: $2.753 per Deferred Stock Unit acquired on April 1, 2022. The price of each Deferred Stock Unit acquired prior to April 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.